Release Date: January 31, 2023
Expiration Date: January 31, 2024
Activity Overview
This online activity is designed to provide concise and easy-to-digest education in an engaging and interactive case-based format on recognizing the signs and symptoms of pediatric atopic dermatitis and choosing the most appropriate therapy based on the clinical scenario. The engaging format of this program includes interactive clinical decision points with explanations at the end of the activity, and an evidence-based review supporting the teaching points covered in the case.
Target Audience
This educational activity is directed toward dermatologists, pediatricians, specialty NPs and PAs, and nurses involved in the management of pediatric patients with moderate to severe atopic dermatitis.
Learning Objective
Upon successful completion of this activity, you should be better prepared to:
- Develop an appropriate treatment plan for pediatric patients with moderate to severe AD
Caroline Mann, MD
Johannes Gutenberg University Hospital
Clinical Research Center, Department of Dermatology
Mainz, Germany
Disclosures: Deputy clinical studies/travel or conference fees: Almirall, Lilly, Pfizer, Sanofi.
Raj Chovatiya, MD, PhD, FAAD
Assistant Professor of Dermatology
Northwestern University Feinberg School of Medicine
Chicago, IL
Disclosures: Consultant: AbbVie, Arcutis, Arena, argenx, ASLAN, Beiersdorf, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Dermavant, EPI Health, Incyte, Lilly, LEO Pharma, L’Oréal, National Eczema Association, Pfizer, Regeneron, Sanofi, UCB; Speaker’s Bureau: AbbVie, Arcutis, Dermavant, Lilly, EPI Health, Incyte, LEO Pharma, Pfizer, Regeneron, Sanofi, UCB.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
